Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron Feb 12, 2021 9:57am

49 Views

Post# 32551166

market depth been waiting for the TD tree shaker offer

Special terms and non-boardlot orders do not appear in Depth by Price +Vertical +Columnar +Horizontal

V:VXL Depth by Order @09:55:58

Bid			Ask
Broker	Size	Price	Price	Size	Broker
7 TD Sec	3,000	0.47	0.485	15,500	80 National Bank
9 BMO Nesbitt	5,000	0.47	0.485	1,000	79 CIBC
2 RBC	500	0.47	0.485	500	79 CIBC
7 TD Sec	15,000	0.47	0.485	500	79 CIBC
7 TD Sec	28,000	0.47	0.49	500	80 National Bank
9 BMO Nesbitt	5,000	0.47	0.49	5,000	9 BMO Nesbitt
80 National Bank	10,000	0.465	0.49	100,000	7 TD Sec
7 TD Sec	20,000	0.465	0.49	1,000	79 CIBC
124 Questrade	3,700	0.465	0.49	500	79 CIBC
79 CIBC	1,500	0.465	0.49	500	79 CIBC